Skip to main content
Caplight Logo









Atommerce

Atommerce

Private
SeoulHealthcare & Life Scienceshttps://www.atommerce.com/

Last Round

Series B

Extension

Jan 9, 2023

Total Funding Raised

$28.32M

Company Overview

Atommerce is a digital mental healthcare company that operates Mind Cafe, a platform providing online psychological counseling, coaching, and mental health management services for individuals and corporate clients.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

mental healthcare platformteletherapyemployee assistance programEAPonline counselingmental health appcorporate wellnesspsychological counselingdigital healthtelemedicinemental health communityB2B mental healthAI mental healthemployee mental healthwellness tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atommerce Comparables

Compare Atommerce with similar companies based on industry and business-model similarity.

Atommerce comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Intellect
79%
40FY Inc.
78%
Aimmed
76%

Atommerce Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 9, 2023
Series BFeb 7, 2022
Series A ExtensionSep 1, 2020
Series AOct 15, 2019
SeedOct 24, 2018

Atommerce Investors

Notable investors and investment history

Atommerce investors
InvestorRounds
Kite Entrepreneurship FoundationSeed
K2 Investment PartnersSeries B
NewFlightSeed
Samsung Venture InvestmentSeries B Extension
Samsung Next TLVSeries B
Insight EquitySeries A Extension, Series B
HashedSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2025

    Monthly visitors grew 405% MoM, reaching 10.6K.

  • Nov 18, 2024

    Monthly visitors grew 380% MoM, reaching 9.6K.

Atommerce Filings

Explore SEC and related filing metadata, where available.

Atommerce filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Atommerce's valuation, stock price, and market status.

Is Atommerce a public or private company?

Atommerce is a private company.

What is the current stock price of Atommerce?

Atommerce is a private company with no public stock price. No recent secondary market data is available.

How much is Atommerce worth (valuation)?

Valuation information for Atommerce is not publicly available.

Can I buy Atommerce stock?

Atommerce shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Atommerce's last funding round?

Atommerce's most recent funding round was Series B Extension on January 9, 2023.

Who are the main investors in Atommerce?

Key investors in Atommerce include Hashed.

Will Atommerce IPO soon?

No public IPO plans have been announced for Atommerce.

How can I track Atommerce secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atommerce's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range44
Year Founded2015
Last FundingJan 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?